Lexeo Therapeutics, Inc. · NASDAQ:LXEO

Affinity Asset Advisors, LLC reported a 7.75% stake in Lexeo Therapeutics, Inc. (Schedule 13G)

Event May 28, 2025 · Filed Jun 4, 2025

Affinity Asset Advisors, LLC reported a 7.75% stake in Lexeo Therapeutics, Inc., 4,252,005 shares, as a passive investor on May 28, 2025. Filed Jun 4, 2025 (Schedule 13G).

Stake
7.75%
Shares
4,252,005
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Affinity Healthcare Fund, LP7.75%4,252,005
Affinity Asset Advisors, LLC7.75%4,252,005

Source

View original at SEC

Related